Ausgabe Sonderheft 1/2012
Radiolabelled Peptides for Diagnosis and Therapy
Inhalt (13 Artikel)
Radiolabelled peptides in diagnosis and therapy: an introduction
Adil AL-Nahhas, Stefano Fanti
Rationale for the use of radiolabelled peptides in diagnosis and therapy
K. P. Koopmans, A. W. J. M. Glaudemans
Radiopharmaceutical development of radiolabelled peptides
Melpomeni Fani, Helmut R. Maecke
Feasibility and availability of 68Ga-labelled peptides
Clemens Decristoforo, Roger D. Pickett, Alfons Verbruggen
Somatostatin receptor SPECT
Giovanna Pepe, Roy Moncayo, Emilio Bombardieri, Arturo Chiti
68Ga-labelled peptides for diagnosis of gastroenteropancreatic NET
Valentina Ambrosini, Davide Campana, Paola Tomassetti, Stefano Fanti
68Ga-labelled peptides in the management of neuroectodermal tumours
Meeran Naji, Adil AL-Nahhas
Gallium-labelled peptides for imaging of inflammation
Anne Roivainen, Sirpa Jalkanen, Cristina Nanni
Radiolabelled peptides for oncological diagnosis
Peter Laverman, Jane K. Sosabowski, Otto C. Boerman, Wim J. G. Oyen
Yttrium-labelled peptides for therapy of NET
Lisa Bodei, Marta Cremonesi, Chiara M. Grana, Marco Chinol, Silvia M. Baio, Stefano Severi, Giovanni Paganelli
Lutetium-labelled peptides for therapy of neuroendocrine tumours
B. L. R. Kam, J. J. M. Teunissen, E. P. Krenning, W. W. de Herder, S. Khan, E. I. van Vliet, D. J. Kwekkeboom
111In-DTPA0-octreotide (Octreoscan), 131I-MIBG and other agents for radionuclide therapy of NETs
Jamshed B. Bomanji, Nikolaos D. Papathanasiou
Radiolabelled RGD peptides for imaging and therapy
F. C. Gaertner, H. Kessler, H.-J. Wester, M. Schwaiger, A. J. Beer